We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diagnostic Sensitivity of Kato-Katz Technique Estimated

By LabMedica International staff writers
Posted on 17 Oct 2017
Print article
Image: Hookworm eggs examined microscopically on wet mount using the Kato-Katz technique (eggs of Ancylostoma duodenale and Necator americanus cannot be distinguished morphologically. The embryo in (B) has begun cellular division and is at an early (gastrula) developmental stage (Photo courtesy of Vishnu Vardhan Serla / Maheep Sangha).
Image: Hookworm eggs examined microscopically on wet mount using the Kato-Katz technique (eggs of Ancylostoma duodenale and Necator americanus cannot be distinguished morphologically. The embryo in (B) has begun cellular division and is at an early (gastrula) developmental stage (Photo courtesy of Vishnu Vardhan Serla / Maheep Sangha).
Soil-transmitted helminthiasis (STH) and schistosomiasis are two of the most prevalent neglected tropical diseases with more than one billion and over 250 million people affected worldwide, respectively.

The Kato-Katz technique is the most widely used diagnostic method in epidemiologic surveys and drug efficacy trials pertaining to intestinal schistosomiasis and soil-transmitted helminthiasis. However, the sensitivity of the technique is low, particularly for the detection of light-intensity helminth infections.

Scientists at the Swiss Tropical and Public Health Institute (Basel, Switzerland) and their African colleagues tested their model performing a secondary analysis based on the Kato-Katz assay, hookworm prevalence varied from 11.4% to 59.0%, and mean or infected population based infection intensity from 280 eggs per gram of stool (EPG) to 396 EPG. For Schistosoma mansoni, prevalence varied from 35.6% to 76.3%, and infection intensity from 152 EPG to 307 EPG. Between two and four stool samples were collected and analyzed on consecutive days of a total of 1,423 participants.

The a model which estimates the sensitivity of the Kato-Katz technique in Schistosoma mansoni and hookworm, as a function of infection intensity for repeated stool sampling and provide estimates of the age-dependent ‘true’ prevalence. The team found that the sensitivity for S. mansoni diagnosis is dominated by missed light infections, which have a low probability to be diagnosed correctly even through repeated sampling. The overall sensitivity strongly depends on the mean infection intensity. In particular at an intensity of 100 eggs per gram of stool (EPG), they estimated a sensitivity of 50% and 80% for one and two samples, respectively.

The team reported that at an infection intensity of 300 EPG, they estimated a sensitivity of 62% for one sample and 90% for two samples. The sensitivity for hookworm diagnosis is dominated by day-to-day variation with typical values for one, two, three, and four samples equal to 50%, 75%, 85%, and 95%, respectively, while it is only weakly dependent on the mean infection intensity in the population. The sensitivity was strongly associated with S. mansoni infection intensity. In particular, for very light infections ( less than five EPG), it was below 50% even after three samples.

The authors recommend collecting at least two stool samples over subsequent days combined with the given sensitivity values to estimate ‘true’ prevalence. For S. mansoni infection the sensitivity is largely driven by light infections that are hard to detect by a single Kato-Katz thick smear. They also recommend collecting two samples due to almost perfect sensitivity for moderate and heavy infections and low benefit of additional samples for light infections. They predict that improving the sensitivity for S. mansoni can be achieved more cost effectively by increasing the number of Kato-Katz thick smears from the same stool sample instead of increasing the number of samples taken. The study was published on October 4, 2017, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Swiss Tropical and Public Health Institute

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAb Immunoassay
Chorus TRAb
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.